A study of the implications of the hypothesis that high energy processes involving cosmic rays acting on the interstellar medium are the sources of the elements Li, Be and B present in stellar atmospheres and in the solar system.
Observations of Be and B in low-metallicity halo stars formed during the Ðrst 109 yr of Galactic evolution show that cosmic-ray acceleration must have taken place in the early Galaxy. The observed abundances of these elements relative to Fe, which, in the early Galaxy, is almost exclusively produced in Type II supernovae, strongly suggest that the cosmic-ray acceleration is also related to such supernovae with the particles being accelerated out of freshly nucleosynthesized matter before it mixes into the ambient, essentially nonmetallic interstellar medium. The observed abundances require that about 3 ] 1049 to 2 ] 1050 ergs per Type II supernova be imparted to these metallic cosmic rays, depending on whether or not H and He are accelerated along with the metals. The current data, however, are not sufficient to decide whether these cosmic rays are predominantly low energy or high energy. But, in any case, arguments of energetics imply a hard-energy spectrum extending up in energy to at least 50 MeV nucleon~1. This rules out Be and B production by supernova ejecta without further acceleration. In addition to production by cosmic rays, there must also be signiÐcant 11B production by neutrinos. This argument is driven by the observed 11B/10B ratio in meteorites that is very difficult to reproduce by cosmic-ray interactions. Observations of 6Li and Li in the early Galaxy provide information on the acceleration of nonmetallic cosmic rays out of the interstellar medium.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.